Literature DB >> 27815711

The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.

Horia Vulpe1, Janet Ellis2, Shao Hui Huang1, Eshetu G Atenafu3, Raymond W Jang4, Gary Rodin5, Jolie Ringash6.   

Abstract

PURPOSE: We aim to identify the risk factors for a "rocky" treatment course (RTC) in head and neck cancer.
METHODS: A retrospective case-control study was conducted utilizing data from a prospective study. We defined the RTC as a composite of adverse outcomes including G-tube dependence and increased nursing interventions. Statistically associative variables were included in a multivariable logistic regression. We also evaluated whether the RTC, or its components, associated with worse cancer outcomes.
RESULTS: Being single, unemployed, having N2/3 disease and receiving chemoradiotherapy were associated with a RTC. In turn, G-tube dependence was associated with worse 3-year OS (73 vs 91 %; p = 0.02) and increased nursing interventions with worse 3-year locoregional recurrence-free survival (LRFS) (85 vs 92 %; p = 0.03) and locoregional recurrence (LRR) (14 vs 7 %; p = 0.03).
CONCLUSIONS: We identified baseline factors associated with a RTC for head and neck cancer patients. Future supportive care interventions could be evaluated using the RTC as a marker of benefit.

Entities:  

Keywords:  Head and neck cancer; Radiotherapy; Supportive interventions

Mesh:

Year:  2016        PMID: 27815711     DOI: 10.1007/s00520-016-3450-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  37 in total

1.  Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

Authors:  Patti A Groome; Brian O'Sullivan; William J Mackillop; Lynda D Jackson; Karleen Schulze; Jonathan C Irish; Padraig R Warde; Ken M Schneider; Robert G Mackenzie; D Ian Hodson; J Alex Hammond; Sunil P P Gulavita; Libni J Eapen; Peter F Dixon; Randy J Bissett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-18       Impact factor: 7.038

Review 2.  Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials.

Authors:  Nitin Ohri; Xinglei Shen; Adam P Dicker; Laura A Doyle; Amy S Harrison; Timothy N Showalter
Journal:  J Natl Cancer Inst       Date:  2013-03-06       Impact factor: 13.506

3.  Point-of-care outcome assessment in the cancer clinic: audit of data quality.

Authors:  Karen Wong; Shao Hui Huang; Brian O'Sullivan; Gina Lockwood; Darlene Dale; Terry Michaelson; John Waldron; Andrew Bayley; Bernard Cummings; Laura A Dawson; John Kim; Geoffrey Liu; Jolie Ringash
Journal:  Radiother Oncol       Date:  2010-03-31       Impact factor: 6.280

Review 4.  A review of research on the Alcohol Use Disorders Identification Test (AUDIT).

Authors:  J P Allen; R Z Litten; J B Fertig; T Babor
Journal:  Alcohol Clin Exp Res       Date:  1997-06       Impact factor: 3.455

5.  Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.

Authors:  C Robertson; A G Robertson; J H Hendry; S A Roberts; N J Slevin; W B Duncan; R H MacDougall; G R Kerr; B O'Sullivan; T J Keane
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

6.  Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

Authors:  W Duncan; R H MacDougall; G R Kerr; D Downing
Journal:  Radiother Oncol       Date:  1996-12       Impact factor: 6.280

7.  Patient navigation for breast and colorectal cancer treatment: a randomized trial.

Authors:  Kevin Fiscella; Elizabeth Whitley; Samantha Hendren; Peter Raich; Sharon Humiston; Paul Winters; Pascal Jean-Pierre; Patricia Valverde; William Thorland; Ronald Epstein
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10       Impact factor: 4.254

Review 8.  Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.

Authors:  Nuran Senel Bese; Jolyon Hendry; Branislav Jeremic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-30       Impact factor: 7.038

9.  Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients.

Authors:  Radhika Sreeraman; Srinivasan Vijayakumar; Allen M Chen
Journal:  Support Care Cancer       Date:  2013-07-28       Impact factor: 3.603

10.  Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation.

Authors:  Kathleen Ell; Betsy Vourlekis; Bin Xie; Frances R Nedjat-Haiem; Pey-Jiuan Lee; Laila Muderspach; Christy Russell; Lawrence A Palinkas
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

View more
  1 in total

1.  Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma.

Authors:  Alexandre Arthur Jacinto; Eronides Salustiano Batalha Filho; Luciano de Souza Viana; Pedro De Marchi; Renato de Castro Capuzzo; Ricardo Ribeiro Gama; Domingos Boldrini Junior; Carlos Roberto Santos; Gustavo Dix Junqueira Pinto; Josiane Mourão Dias; Heloisa Pelisser Canton; Raiany Carvalho; Lucas Augusto Radicchi; Soren Bentzen; Eduardo Zubizarreta; Andre Lopes Carvalho
Journal:  BMC Cancer       Date:  2018-10-23       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.